Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4

Type 2 diabetes (T2D)-associated end-stage kidney disease (ESKD) is a global burden, while the renoprotective effects of metformin remain controversial. In a population-based cohort (2002–2018) including 96,643 patients with T2D observed for 0.7 million person-years, we estimated the risk associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Aimin, Lau, Eric S. H., Wu, Hongjiang, Ma, Ronald C. W., Kong, Alice P. S., So, Wing Yee, Luk, Andrea O. Y., Fu, Amy W. C., Chan, Juliana C. N., Chow, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505840/
https://www.ncbi.nlm.nih.gov/pubmed/36145361
http://dx.doi.org/10.3390/ph15091140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505840/
https://www.ncbi.nlm.nih.gov/pubmed/36145361
http://dx.doi.org/10.3390/ph15091140

Ejemplares similares